Invivyd Announces U.S. IND Clearance and FDA Alignment for VYD2311 COVID Prevention Program

Invivyd announced that the FDA has cleared its IND application and provided feedback to advance its REVOLUTION clinical program for VYD2311, a vaccine...
Home/KnloSights/Clinical Trial Updates/Invivyd Announces U.S. IND Clearance and FDA Alignment for VYD2311 COVID Prevention Program